Study Demonstrates Electrical Stimulation Therapy Safe And Well-Tolerated In Early Stage Retinitis Pigmentosa Patients
Okuvision GmbH, an innovator in the field of electrical stimulation therapy (EST) for early and intermediate stage retinitis pigmentosa patients, today announced the presentation of data from the company's first sham-controlled pilot study at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting...